Skip to content

SCREENER CHART SD50 CALENDAR NEWS

...

Elite Pharmaceuticals, Inc. (ELTP) Stock · SELL · RECOVERY | LOPJLB

Elite Pharmaceuticals, Inc. (ELTP)

Healthcare · Drug Manufacturers - Specialty & Generic · OTC · US

$0.25+4.17%Close

SELLRECOVERY · day 2

ELTP▼ SELL

$0.25+4.17%

Overview FinancialsFin EarningsEarn Analyst & RatingsAnalyst News Holders & ETFsHold Options

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $269M
Beta: 0.40
P/E (TTM): 4.90

Short % float: 0.31%
Days to cover: 1.6
SI change: +2.3%

1W: +4.17%
1M: -3.85%

vs SPY 1W: +2.25%
vs SPY 1M: -5.57%

Industry peers

FMP comparable companies · ranked by market cap

BPMUFBasilea Pharmaceutica AG$958M$77.40
GLASFGlass House Brands Inc.$852M$10.79
AGYTFAllergy Therapeutics plc$756M$0.15
TRXPFTorii Pharmaceutical Co., Ltd.$691M$24.57
YIHCFYiChang HEC ChangJiang Pharmaceutical Co., Ltd.$643M$0.55
BOIRFBoiron S.A.$547M$31.50

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Elite Pharmaceuticals, Inc. (ELTP) is a specialized pharmaceutical company focused on the creation and manufacturing of generic medications, as well as oral, controlled-release drug formulations. Its business activities are primarily divided into two segments: Abbreviated New…

Employees: 65
Headquarters: US
Founded: 2000
Exchange: OTC
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares out: 1.1B
Float: 77.6%

elitepharma.com ↗

Key executives

Nasrat Hakim — Chairman, Chief Executive Officer & President

Douglas Plassche — Executive Vice President of Operations

Carter J. Ward CSCP — Chief Financial Officer, Secretary & Treasurer

SEC filings

EDGAR · CIK 10533690 · ELTP

All filings
10-K
10-Q
8-K
Form 4

Company news

zacks.com · 1d ago

Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy?

zacks.com · 28d ago

ELTP Downgraded to Neutral on Pricing Pressure & Limited Visibility

zacks.com · 44d ago

ELTP vs. DERM: Which Specialty Pharmaceutical Stock Is the Better Buy?

zacks.com · 50d ago

Elite Pharmaceuticals Stock Plunges Post Q1 Earnings, Revenues Fall Y/Y

seekingalpha.com · 55d ago

Elite Pharmaceuticals, Inc. (ELTP) Q1 2027 Earnings Call Transcript

marketbeat.com · 55d ago

Elite Pharmaceuticals Q1 Earnings Call Highlights

newsfilecorp.com · 56d ago

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call Information

newsfilecorp.com · 59d ago

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter of Fiscal Year 2027 Financial Results on August 14, 2026

newsfilecorp.com · 66d ago

Elite Pharmaceuticals Announces Commercial Launch of Generic Requip XL

defenseworld.net · 66d ago

Elite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Passes Below Two Hundred Day Moving Average – Time to Sell?

zacks.com · 70d ago

Possible Generic Drug Tariffs and 2 Microcaps

zacks.com · 85d ago

ELTP vs. CPIX: Which Pharma Stock Is the Better Buy Right Now?

Market news & ticker search · RSS for ELTP

LOPJLB

Independent quant research on U.S. equities & ETFs. Not personalized advice.

Product

Screener Chart Compare SD50 Thesis News Calendar

Desk

Market Heatmap Market Hours FOMC Desk Treasury Rates Congress Trades Prediction Markets

Research

How It Works Methodology Track Record Editorial Blog Changelog

Ledgers

Bull Spreads Cash-Secured Puts Covered Calls Long Puts Long Calls

Screeners

CEF Screener REIT Screener BDC Screener Preferred Screener Dividend Screener ETF Screener Crypto Screener S&P 500 Screener

Company

Pricing About Contact

Agents

GitHub·Research Chat·MCPENT·Developers

© 2026 LOPJLB Research. All rights reserved.

@lopjlb contact@lopjlb.com

RANGE

LOPJLB.COM

OHLC🔒EMALEVELS🔒STOP🔒FLIP🔒52WSIGNALS🔒BUY🔒SELL🔒EXH🔒EXH ZONE